The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL

The conditional survival of patients after frontline therapy for diffuse large B-cell lymphoma (DLBCL) approaches that of the general population once patients have survived disease free for 2 years. We sought to determine the conditional survival of patients among patients with relapsed de novo DLBC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Assouline, Sarit, Li, Shen, Gisselbrecht, Christian, Fogarty, Patrick, Hay, Annette, van den Neste, Eric, Shepherd, Lois E., Schmitz, Norbert, Baetz, Tara, Keating, Armand, Robinson, Sue, Seftel, Matthew, Stelitano, Caterina, Djurfeldt, Marina S., Meyer, Ralph, Chen, Bingshu E., Crump, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7218426/
https://ncbi.nlm.nih.gov/pubmed/32396614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001646
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados